Keyphrases
Alzheimer's Disease
63%
Tau Oligomers
58%
Amyloid-β Oligomers
37%
Tauopathy
32%
Neurodegenerative Diseases
26%
Oligomeric
23%
Alpha-synuclein (α-syn)
18%
Tau Aggregates
14%
Neurofibrillary Tangles
11%
Amyloid Protein
10%
Amyloid Fibrils
9%
Tau Aggregation
9%
Oligomeric tau
9%
Neurodegeneration
9%
Alzheimer's Disease Model
8%
Synaptic Dysfunction
8%
Brain-inspired
8%
Toxic Species
8%
Alzheimer's Disease Brain
7%
Parkinson's Disease
7%
Mouse Model
7%
Tau Pathology
7%
Pathological tau
7%
Oligomerization
7%
Monoclonal Antibody
7%
Oligomer Formation
6%
Amyloidosis
6%
Amyloid beta
6%
Tg2576 Mice
6%
Progressive Supranuclear Palsy
5%
Annular Protofibrils
5%
Dementia with Lewy Bodies
5%
Alzheimer
5%
Oligomer Toxicity
5%
Plaque
5%
Toxic Oligomers
5%
Transgenic Mice
5%
Passive Immunity
5%
Neurodegenerative
5%
Small Molecules
5%
Therapeutic Target
5%
Neuroscience
Oligomer
100%
Alzheimer's Disease
66%
Amyloid Protein
51%
Tauopathy
30%
Neurodegenerative Disorder
20%
Immunotherapy
17%
Synuclein
12%
In Vivo
11%
Neurodegeneration
9%
Monoclonal Antibody
8%
Tau Protein
8%
Beta Amyloid
6%
In Vitro
6%
Amyloidosis
6%
Progressive Supranuclear Palsy
5%
Parkinson's Disease
5%
Calcineurin
5%
Dementia with Lewy Bodies
5%
Cognitive Disorders
5%
Hippocampus
5%
Biochemistry, Genetics and Molecular Biology
Tau
69%
Amyloid Protein
45%
Conformation
13%
Synuclein
13%
Mouse Model
7%
Neurofibrillary Tangle
5%
Tau Protein
5%
Small Molecule
5%
Oligomerization
5%